This book series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the book series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.
Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.
The seventh volume of this series features 7 chapters that cover the following topics:
- Gut micriobiota and gastrointestinal cancer
- Dengue virus infections
- Synergistic antibiotic drug interactions
- Molecular modelling of antibacterial drugs
- Nucleic acid aptamers as anti-infective agents
- Fungal multidrug resistance
- The role of hydrogen sulfide in infections
Table of Contents
Chapter 1 The Role Of The Microbiota In The Genesis Of Gastrointestinal Cancers
- Edda Russo And Amedeo Amedei
- Introduction
- The Human Microbiota
- The Gastrointestinal Microbiota
- Composition And Activities
- Gastro-Intestinal Colonization By The Microbiota And Selection
- The Human Microbiome Project
- Gut Enterotypes
- The Role Of Microbiota In Tumor Development
- Proposed Models For Microbiota-Induced Carcinogenesis
- Antibacterial-Specific Immune Response And Cancer Promotion
- Microbiota And Gi Cancers
- Gut Bacteria Dysbiosis Associated With Gi Cancer
- Microbiota Involvement In Gastric And Esophageal Cancers, The Role Of Helicobacter Pylori
- Microbiota Involvement In Colorectal Cancer
- Specific Gut Bacteria And Crc
- Bacteria Metabolites And Crc
- Gallbladder Cancer
- Liver Cancer
- Pancreatic Cancer
- Beneficial Activities Of Gut Microbiota
- Antitumorigenic Impact Of Microbiota
- Manipulating The Microbiota For Cancer Therapy
- Conclusion
- Consent For Publication
- Conflict Of Interest
- Acknowledgements
- References
Chapter 2 Towards Host Cell-Targeting Therapies To Treat Dengu Virus Infections
- Cybele C García, Verónica M Quintana, Viviana Castilla And Elsa B Damonte
- Introduction
- Interaction With Cell Receptors
- Endocytosis And Fusion For Uncoating
- Lipid Metabolism
- Protein Translation
- Unfolded Protein Response
- Ubiquitin Proteasome Pathway
- Nucleotide Metabolism
- Kinases
- Mitogen-Activated Protein Kinases
- Erk Pathway
- Jnk Pathway
- P38 Pathway
- Other Kinases
- Src, Ab1 And Fyn Kinases
- Ap2-Associated Protein Kinase 1 And Cyclin G-Associated Kinase
- Phosphatidylinositol 3 Kinase/Akt Pathway
- Protein Processing
- Endoplasmic Reticulum A-Glucosidases
- Furin
- Endoplasmic Reticulum Associated Signal Peptidase
- Innate Antiviral Response
- Interferon Activity
- Cell-Intrinsic Restriction Factors
- Concluding Remarks
- Consent For Publication
- Conflict Of Interest
- Acknowledgements
- References
Chapter 3 Synergistic Interaction Between Plant Products And Antibiotics Against Potential Pathogenic Bacteria
- Banasri Hazra, Sutapa Biswas Majee, Subhalakshmi Ghosh And Dhruti Avlani
- Introduction
- Bacterial Resistance Towards Clinical Antibiotics
- Background
- Mechanisms And Associated Factors
- Screening Strategies To Characterise Plant Products With
- Potential Resistance Modifying Activity
- Assessment Of Synergistic Interaction Between Antibiotic And A
- Phytocompound Against Resistant Bacteria
- Fractional Inhibitory Concentration Index (Fici)
- Modulation Factor (Mf)
- Isobologram
- Search For Plant-Derived Secondary Metabolites With
- Prospective Resistance Modifying Activity
- Key Early Studies Pertaining To Discovery Of Rmas From Plants
- Recent Studies
- Phytochemicals And Relevant Bacterial Resistance Mechanisms
- Efflux Pump Inhibition
- Alteration Of Bacterial Cell Membrane Permeability
- Protein Synthesis Inhibition
- Enzymatic Inhibition
- Biofilm Formation Inhibition
- Additional Strategies For Screening And Development Of Plant
- Products As Adjuvants In Antimicrobial Therapy
- In Vivo Validation
- Standardisation Of Botanical Extracts
- Ichip Technology
- Concluding Remarks
- Consent For Publication
- Conflict Of Interest
- Acknowledgements
- Abbreviations
- References
Chapter 4 Molecular Modelling Approaches To Antibacterial Drug Design And Discovery
- Agnieszka A Kaczor, Prasanthi Medarametla, Damian Bartuzi, Magdalena Kondej,
- Dariusz Matosiuk And Antti Poso
- Introduction
- Challenges In Design And Discovery Of Antibacterial Drugs
- Drug Targets For Antibiotics
- Molecular Modelling Techniques For Design And Discovery Of
- Antibacterial Drugs
- Protein 3D Structure Prediction
- Comparative/Homology Modelling
- Fold Recognition/Threading
- Ab Initio Modelling
- Protein Structure Prediction In Anti-Bacterial Drug Design
- Molecular Docking
- Molecular Docking As An Approach To Study Ligand-Protein Interactions
- Application Of Molecular Docking In Anti-Bacterial Drug Discovery
- Molecular Dynamics
- Molecular Dynamics As An Approach To Study Dynamic Aspects Of Ligand-Protein
- Interactions
- Application Of Molecular Dynamics For Antibacterial Drug Discovery
- Qsar
- Qsar As A Method Applied In Drug Design
- Application Of Qsar For Antibacterial Drug Discovery
- Pharmacophore Models
- Importance Of Pharmacophore Models In Drug Design
- Application Of Pharmacophore Models For Antibacterial Drug Discovery
- Virtual Screening
- Virtual Screening As A Method Of Searching Large Databases
- Application Of Virtual Screening For Antibacterial Drug Discovery
- Prediction Of Drug-Likeness And Admet Properties
- Summary And Perspective
- Consent For Publication
- Conflict Of Interest
- Acknowledgements
- References
Chapter 5 Nucleic Acid Aptamers Against Virulence Factors Of Drug Resistant Pathogens
- Canan Ozyurt, Ozge Ugurlu, Burhan Bora And Serap Evran
- Introduction
- Selection Of Aptamers
- Aptamers Against Toxins And Protein Virulence Factors
- Aptamers Against Staphylococcal Toxins
- Aptamers Against Clostridium Toxins
- Aptamers Against E Coli Toxins
- Aptamers Against Aspergillus And Penicillium Toxins
- Aptamers Against Mycobacterium Tuberculosis Toxins
- Aptamers Against Other Toxins
- Aptamers Against Quorum Sensing Molecules
- Modifications Of Aptamers For Improving Therapeutic Potential
- 2'-F-Modified Rna Aptamers
- 2'-Nh2 Modification Of Aptamers
- Other Ribose Modified Aptamers
- Phosphorothioate Modification
- Nucleobase Modification Of Aptamers
- Concluding Remarks
- Consent For Publication
- Conflict Of Interest
- Acknowledgement
- References
Chapter 6 Overcoming Fungal Multidrug Resistance By Natural Compounds Targeting Efflux Pumps
- Shweta Singh, Sandeep Hans, Zeeshan Fatima
- And Saif Hameed
- Introduction
- Candida Efflux Pumps
- Abcs Transporter Family
- Mfs Transporter Family
- Natural Epi Targeting Abc Transporters
- Natural Epi Targeting Mfs Transporters
- Conclusion
- Consent For Publication
- Conflict Of Interest
- Acknowledgements
- References
Chapter 7 The Infections And Hydrogen Sulfide
Author
- Atta-ur-Rehman
- Iqbal Chaudhry